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Activation of Wnt/b-Catenin Signalling Affects
Differentiation of Cells Arising from the Cerebellar
Ventricular Zone
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Centre for Integrative Physiology, School of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom
Abstract
Development of the cerebellum proceeds under the precise spatio-temporal control of several key developmental signalling
pathways, including the Wnt/b-catenin pathway. We recently reported the activity of Wnt/b-catenin signalling in the
perinatal cerebellar ventricular zone (VZ), a germinal centre in the developing cerebellum that gives rise to GABAergic and
glial cells. In order to investigate the normal function of Wnt/b-catenin signalling in the VZ and the cell lineages it gives rise
to, we used a combination of ex vivo cerebellar slice culture and in vivo genetic manipulation to dysregulate its activity
during late embryonic development. Activation of the pathway at the cerebellar ventricular zone led to a reduction in the
number of cells expressing the glial lineage markers Sox9 and GFAP and the interneuron marker Pax2, but had no consistent
effect on either proliferation or apoptosis. Our findings suggest that activation of the Wnt/b-catenin pathway in the
cerebellar ventricular zone causes a shift in the cell types produced, most likely due to disruption of normal differentiation.
Thus, we propose that regulation of Wnt/b-catenin signalling levels are required for normal development of cells arising
from the cerebellar ventricular zone during late embryogenesis.
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Introduction
The adult cerebellum contains a variety of types of neurons and
glia, arranged in a highly characteristic laminar structure. At the
centre of the cerebellum sits the white matter (WM), consisting of
axonal tracts surrounding three clusters of deep cerebellar nuclei
(DCN). Outside the WM sits the internal granule layer (IGL),
densely populated by glutamatergic granule cells (GCs), c-
aminobutyric acid (GABA)ergic interneurons and protoplasmic
astrocytes. Above the IGL sits the Purkinje cell (PC) layer (PCL),
which contains the cell bodies of PCs arranged in a characteristic
monolayer and interspersed with Bergmann glia (BG). PCs, GCs
and Bergmann glia all extend processes into the cell-sparse
molecular layer (ML), which contains a further population of
interneurons (reviewed in [1,2]).
The principal cell lineages of the cerebellum arise in a well-
defined temporal manner, beginning at around embryonic day
(E)10.5 in the mouse. Cells arise from two distinct germinal
centres - the ventricular zone (VZ) - which lines the dorsal aspect
of the fourth ventricle, and the upper rhombic lip (URL) – a
transient structure at the caudal limit of the cerebellum [3]. The
VZ gives rise to all cerebellar GABAergic neurons and glia,
beginning with the birth of GABAergic DCN neurons at E10.5
[4,5] and followed by the PCs, which are born in waves until
E13.5 [5,6,7]. The VZ also generates Bergmann glia which follow
the radial migration of PCs towards the pial surface [8,9].
Interneurons and the remaining glia are then generated
sequentially from the VZ and subsequently from progenitors
that delaminate and continue to divide in the presumptive WM
before migrating to their final positions – a process that continues
into early adulthood [5,10,11,12,13]. In contrast, the upper
rhombic lip gives rise to all of the glutamatergic neuron types in
the cerebellum. Glutamatergic DCN neurons are specified first,
from E10.5. These migrate rostrally from the URL, across the
dorsal surface of the cerebellum. From E12.5, the URL gives rise
to granule progenitor cells (GPCs) which stream across the pial
surface of the cerebellum to form the external granule layer
(EGL). The GPCs in the EGL proliferate extensively from
around E18.5, continuing into the first two postnatal weeks.
Following their terminal mitosis, GCs migrate inwards through
the PCL to reside in the IGL – a process that is largely complete
by P21 [2].
It is likely that many aspects of this developmental programme
are under the control of intercellular signalling pathways. Indeed,
both sonic hedgehog (Shh) and fibroblast growth factor (FGF)
signalling are known to play important roles in cerebellum
development [14,15,16,17]. Wnt/b-catenin signalling plays a
wide variety of roles at multiple stages of neural development
(reviewed in [18,19]) and is known to be required for the earliest
stages of cerebellum development [20,21]. Only recently has a
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developmental role for the pathway beyond this point been
revealed. Pei et al. [22] identified differential effects on self-
renewal, differentiation and proliferation of VZ and RL
progenitors within the developing cerebellum after constitutive
activation of the pathway.
Further support for a developmental function of the Wnt/b-
catenin signalling pathway has been revealed from investigations
into the cerebellar malignancy medulloblastoma. Activating
mutations in multiple components of the pathway have been
identified in tumour samples [23,24,25,26,27] and one well-
defined subtype of medulloblastoma displays consistent hallmarks
of Wnt/b-catenin pathway activation [28,29,30,31]. While a
recent study has suggested that activating mutations in the Wnt/b-
catenin pathway can generate medulloblastoma from progenitors
within the dorsal hindbrain [32], this does not rule out the
possibility that the Wnt/b-catenin pathway could contribute to
tumourigenesis from an intra-cerebellar lineage. Combined with
our emerging understanding of its function during development,
these observations argue that Wnt/b-catenin signalling is required
for cerebellum development and that its dysregulation may
contribute to the aetiology of medulloblastoma.
We recently reported a highly specific spatio-temporal pattern
of Wnt/b-catenin signalling pathway activity in the developing
cerebellum [33]. We showed that Wnt/b-catenin signalling is
active in the ventricular zone from E18.5 and in the cell lineages
radiating from this area throughout postnatal development. To
investigate the potential function of Wnt/b-catenin signalling in
this late embryonic/early postnatal cell population, we activated
the pathway both pharmacologically in cultured cerebellum slices
and by genetic activation in vivo. Activation of Wnt/b-catenin
signalling led to a marked decrease in the production of both
Sox9+ and Pax2+ cell lineages – key markers of glia and
interneurons respectively. This decrease did not correlate with
consistent changes in proliferation or cell death and we propose a
potential role for Wnt/b-catenin signalling in regulating differen-
tiation at the cerebellar ventricular zone.
Results
Wnt/b-catenin signalling is active in a subset of Sox9
expressing cells
At perinatal stages, Wnt/b-catenin signalling is active in the
cerebellar ventricular zone and in cells migrating radially from it
[33]. At this stage the ventricular zone gives rise to two key cell
types, glia and interneurons [5], and we first sought to determine
in which of these lineage(s) Wnt/b-catenin signalling was active.
We used mice hemizygous for the BAT-gal reporter transgene
which contains a lacZ reporter under the control of a b-catenin/
T cell factor (TCF) responsive element and is widely used as an in
vivo reporter of Wnt/-catenin activity [34]. Using double
immunohistochemistry on sections of E18.5 cerebellum from
BAT-gal+ embryos, we examined the expression of the LacZ
protein product b-galactosidase (b-gal) alongside expression of
Pax2, which marks VZ-derived interneurons and their precur-
sors [35,36], and Sox9, which marks both the multipotent VZ
and WM progenitors in addition to cells restricted to the glial
lineage [37,38,39]. We did not find any BAT-gal+ cells that
expressed Pax2 (Fig. 1A–C), indicating that Wnt/b-catenin
signalling is not active in the developing interneuron lineage at
this point. In contrast, the clear majority of BAT-gal+ cells
expressed Sox9 (Fig. 1D–F), indicating that Wnt/b-catenin
signalling at E18.5 is restricted to multipotent progenitors and/
or developing glia.
Inhibition of GSK3b activates Wnt/b-catenin signalling in
cultured cerebellar slices
To evaluate a potential role for Wnt/b-catenin signalling in
regulating aspects of cerebellum development, we first tested the
effect of activating the pathway on development of the
cerebellum in an ex vivo slice culture assay. E18.5 BAT-gal+
cerebellum slices were cultured in the presence of the GSK3b
inhibitors BIO [40,41] or CHIR [42,43], for 24 hours. Both
treatments activated Wnt/b-catenin signalling as evidenced by
expression of the BAT-gal reporter (Fig. 2). The pattern of b-gal
expression in control DMSO-treated slices (Fig. 2A) was identical
to that observed in vivo [33], confirming that the culture protocol
did not noticeably disrupt normal expression of the BAT-gal
reporter. Treatment with 20 mM BIO resulted in increased b-gal
expression (Fig. 2B), most obvious within the dorsal region
including the EGL. Treatment with 50 mM CHIR caused an
even more pronounced increase in BAT-gal reporter expression,
with b-gal expressing cells clearly present throughout all cell
layers of the slice (Fig. 2C).
To quantitate BAT-gal expression, we counted the proportion
of b-gal+ cells in specific regions of each cerebellum slice, as shown
in Fig. 2D. The areas indicated by boxes 1–3 (excluding the area
occupied by the EGL) were designated as dorsal, and the ventral
region in which cells were counted is shown by box 4. We found
significant increases in the proportion of b-gal-expressing cells
within the dorsal region of both BIO and CHIR treated slices
compared to controls (Fig. 2E). However, only CHIR treatment
resulted in a significant increase in b-gal expressing cells within the
ventral region. As additional verification that treatment with the
GSK3 inhibitors activated Wnt/b-catenin signalling, we measured
expression of the endogenous Wnt/b-catenin target gene Axin2
using qRT-PCR on RNA extracted from individual whole slices.
Expression of Axin2 (relative to EIF4A2) was significantly increased
in BIO and CHIR treated slices compared to DMSO-treated
controls (Fig. 2F). Taken together, these data clearly indicate that
treatment with BIO and CHIR successfully activated Wnt/b-
catenin signalling ex vivo in E18.5 cerebellum slices.
Activation of Wnt/b-catenin signalling ex vivo leads to a
decrease in cells expressing glial and interneuron
markers
Given that BAT-gal reporter expression in E18.5 cerebellum
was seen in Sox9 expressing progenitors/glia (Fig. 1F), we first
examined the effects of Wnt/b-catenin pathway activation on
these cells. In DMSO treated control cultures, numerous Sox9-
expressing cells were detected in both dorsal (excluding the EGL)
and ventral regions (Fig. 3A), consistent with the normal pattern of
Sox9 expression in VZ progenitors and their progeny [38,39].
Treatment with BIO led to a decrease in the number of Sox9+
cells in the slice (Fig. 3B,M). An even greater decrease was seen
after treatment with CHIR, with a clear loss of Sox9+ cells along
the VZ (Fig. 3C,M). Quantitation confirmed a significant
reduction in the proportion of Sox9+ cells within the dorsal and
ventral regions of both BIO and CHIR treated slices, with CHIR
producing the greatest effect (Fig. 3M). qRT-PCR analysis of Sox9
mRNA levels in whole slices confirmed that expression was
decreased in response to BIO and CHIR (Fig. 3N).
To confirm the effects of stimulating Wnt/b-catenin signalling
on VZ progenitors and glia, we examined expression of an
additional marker of these cell types, glial fibrillary acidic protein
(GFAP) [44,45,46]. Immunohistochemistry on control slices
revealed high GFAP expression ventrally, in particular along the
VZ and in glial processes radiating from it (Fig. 3D), consistent
Wnt Signalling Affects Cerebellum Development
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with expression in VZ radial glia. Treatment with BIO (Fig. 3E) or
CHIR (Fig. 3F) led to a considerable decrease in GFAP staining
with the expression pattern becoming patchier and less intense.
The extent of staining radiating from the VZ towards the dorsal
region was also notably reduced. As GFAP is cytoplasmic, we were
unable to quantitate cell numbers. However, the qualitative
observation of GFAP immunoreactivity reduction was consistent
with qRT-PCR analysis, which revealed a significant reduction in
relative Gfap expression after treatment with both BIO and CHIR
(Fig. 3O). Combined, these data indicate that activation of the
Wnt/b-catenin signalling pathway at E18.5 altered the profile of
progenitor/glial cells at the VZ and within the developing
cerebellum.
We next investigated whether increased Wnt/b-catenin signal-
ling affected the other cell type born in the cerebellar VZ during
this developmental window, the interneuron lineage, by examining
expression of the transcription factor Pax2. Pax2 is expressed in
lineage restricted interneuron progenitors that arise from multip-
otent VZ or WM progenitors [12,13,36]. In control slices, Pax2+
cells were observed in a widespread pattern throughout the
developing cerebellum (Fig. 3G), consistent with interneurons
being generated at the VZ and radiating dorsally. This pattern of
Pax2 expression was largely maintained in slices treated with BIO
or CHIR, although there was an apparent restriction in the dorsal
extent of Pax2 expression towards the EGL (asterisks in Fig. 3H–I).
Quantitation revealed a general reduction in the number of Pax2+
cells in the dorsal region (although this difference was only
significant in slices treated with CHIR), while ventrally, where
most interneurons are generated at this stage, no difference was
observed (Fig. 3P).
Figure 1. Wnt/b-catenin signalling is active in a subset of Sox9 expressing cells. Fluorescent immunohistochemistry was carried out on
E18.5 sagittal BAT-gal+ cerebellum sections for b-gal (A) and Pax2 (B), but revealed no colocalisation between the two markers (C). Analysis of b-gal
(D) and Sox9 (E) revealed that the clear majority of b-gal+ cells also express Sox9 (F). The boxed region in the schematic indicates the approximate
position of the areas shown in all panels. Scale bar = 20 mm.
doi:10.1371/journal.pone.0042572.g001
Figure 2. Activation of Wnt/b-catenin signalling in cultured cerebellar slices. (A–C) Immunohistochemistry showing b-gal expression in
E18.5 BAT-gal+ cerebellum slices cultured in the presence of DMSO (A), 20 mM BIO (B) or 50 mM CHIR (C). (D) Schematic drawing of cerebellum slice
indicating regions used for quantitation. (E) Graph showing proportion of b-gal expressing cells in specific regions of cultured cerebellum slices.
Statistical comparisons were made between each of the treatment groups and the DMSO control group for each region by a Student’s T-test. (F) qRT-
PCR analysis of Axin2 expression in cultured slices. Each treated group was compared to the DMSO control group by a Student’s T-test. For each test,
n = 3, error bars = SEM, * = p,0.05, ** = p,0.01, *** = p,0.001. Sections were counterstained with TOPRO3. Scale bar = 100 mm. EGL= external granule
layer, IV = fourth ventricle, MB=midbrain, VZ = ventricular zone.
doi:10.1371/journal.pone.0042572.g002
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We next sought to determine the effects of constitutive Wnt/b-
catenin pathway activation on the developing PC population.
While these GABAergic neurons are born at the VZ and become
post mitotic by E13.5, morphological maturation of the individual
PCs and their development into a monolayer proceeds until the
early postnatal period. Immunohistochemistry for the PC marker
Calbindin [47] revealed extensive staining in the developing PCL
in control slices (Fig. 3J), demonstrating that the culture system
does not cause immediate disruption to the cytoarchitecture of the
developing cerebellum. This pattern was largely consistent in both
BIO (Fig. 3K) and CHIR (Fig. 3L) treated slices. However,
quantitation of PC number revealed that in both BIO and CHIR
treated slices, the proportion of Calbindin+ cells was slightly
increased compared to DMSO treated slices, a finding consistent
with a reduction in other cell types.
Activation of Wnt/b-catenin signalling ex vivo increases
proliferation but does not affect apoptosis
One possible explanation for the decreased numbers of Sox9
and Pax2 expressing cells in cerebellum slices treated with BIO or
CHIR could be reduced proliferation of progenitors. To test this
possibility, we added BrdU to the cultures two hours prior to
fixation and determined the proportions of BrdU labelled cells in
the same defined regions of the cultured slices (Fig. 2D). With the
exception of the EGL, DMSO treated control slices showed
relatively few BrdU+ cells scattered throughout both the dorsal
and ventral regions of the slice (Fig. 4A). Slices treated with BIO or
CHIR showed an apparent increase in BrdU labelling throughout
all cell layers (Fig. 4B,C). Quantitation of BrdU labelled cells
supported these observations. There were significant increases in
the proportion of BrdU labelled cells in the dorsal and ventral
regions of both BIO and CHIR treated slices, compared to
DMSO treated controls (Fig. 4G). Thus, reduced proliferation is
unlikely to account for the decrease in Sox9 and Pax2 expressing
cells observed in BIO and CHIR treated slices.
An alternative possible explanation for the reduction in Pax2
and Sox9 expressing cells is an increase in apoptosis. To test this
possibility, we examined cultured slices for expression of the
apoptotic marker Caspase3 [48]. Caspase3 labelled cells were
observed throughout the control slices (Fig. 4D). Treatment with
BIO (Fig. 4E) or CHIR (Fig. 4F) had no apparent effect on the
number or distribution of Caspase3 expressing cells. Quantitation
of Caspase3+ cells confirmed that there were no significant
differences between the DMSO control and either BIO or CHIR
treated slices in any of the regions analysed (Fig. 4H). Thus, the
reduction in Sox9+ and Pax2+ cell numbers observed was not
associated with an increase in cell death.
In utero electroporation of a cre-GFP expression construct
activates Wnt/b-catenin signalling in Apclox/lox mice
We next sought to determine whether these effects of activating
Wnt/b-catenin signalling during cerebellum development could
also be observed in vivo. We used a strain of mice harbouring the
Apc580s conditional allele of Apc [49] hereinafter referred to as
Apclox. In these mice, exon 14 of Apc is flanked by loxP sites and cre-
mediated deletion leads to loss of functional Apc protein, thereby
promoting constitutive Wnt/b-catenin activity [49]. To inactivate
Apc specifically in the VZ, we used in utero electroporation to
deliver a pCAG-Cre-IRES2-EGFP (Cre-GFP) plasmid [50] directly to
progenitors surrounding the fourth ventricle of E13.5 Apclox/lox
embryos (Fig. 5A), the earliest stage at which VZ progenitors of
interneurons and glia could be targeted reliably. Immunohisto-
chemistry on electroporated embryos collected 24 hours later
(E14.5) revealed widespread expression of GFP along the length of
the VZ and in cells and processes radiating from it, indicating that
cells surrounding the fourth ventricle had taken up and expressed
the Cre-GFP plasmid (Fig. 5B). In embryos analysed at E18.5, five
days post electroporation, GFP expression was much more
widespread (Fig. 5C–D), indicating that electroporated cells
and/or their progeny had successfully migrated through the
developing tissue. No obvious differences in the distribution of
GFP labelled cells were observed between Apclox/+ and Apclox/lox
embryos (Fig. 5C, D). In both cases, GFP expressing cells were
evident ventrally and in a widely dispersed pattern throughout the
developing cerebellum. Quantitation revealed no significant
difference in the number of GFP+ cells between Apclox/+ and
Apclox/lox embryos (p = 0.309, Student’s t-test, n = 4), suggesting that
loss of Apc did not affect cell numbers at this stage of development.
To determine whether cre-mediated inactivation of the Apclox
allele led to activation of Wnt/b-catenin signalling, we examined
electroporated Apclox/lox embryos for the ectopic localisation of b-
catenin to the nucleus (Fig. 5E–G). At E14.5, we found no
nuclear b-catenin in any sections analysed (data not shown).
However, at E18.5, a clear majority of GFP+ cells in
electroporated Apclox/lox embryos contained nuclear b-catenin
(Fig. 5E–G). No nuclear b-catenin was seen in any Apclox/+
embryos (data not shown). Quantitation of randomly chosen
fields in ten electroporated Apclox/lox embryos revealed nuclear
localised b-catenin in 82% (66.2%) of GFP+ cells, indicative of
active Wnt/b-catenin activity.
Wnt/b-catenin activation in vivo affects the development
of ventricular zone derived cell lineages
To determine the consequences of activated Wnt/b-catenin
signalling at the VZ in vivo, we first examined expression of the VZ
derived lineage markers Sox9 and Pax2 at E18.5. We used double
immunofluorescence to determine the proportion of electroporat-
ed cells and their progeny (i.e. GFP+ cells) that expressed Sox9
(Fig. 6A–C). Just 6.3% (60.2%) of GFP+ cells in Apclox/lox embryos
expressed Sox9, compared to 34.7% (64.8%) of GFP+ cells in
Apclox/+ controls (Fig. 6C). Similarly, only 20.5% (63.4%) of GFP+
cells in Apclox/lox embryos expressed Pax2, compared to 47.9%
(612.5%) in Apclox/+ control embryos (Fig. 6D–F). Thus, similar to
our findings in cultured slices, activation of Wnt/b-catenin
signalling in vivo led to a reduction in the proportion of Sox9
and Pax2 expressing cells arising from the VZ.
To determine whether activated Wnt/b-catenin signalling
affected proliferation in this setting, we examined the expression
of proliferating cell nuclear antigen (PCNA), a marker of mitotic
cells (Fig. 6G–I). We found a significant reduction in the
Figure 3. Wnt/b-catenin pathway activation ex vivo affects expression of VZ-derived lineage markers. (A–I) E18.5 cerebellum slices were
cultured in the presence of DMSO (A,D,G), 20 mM BIO (B,E,H) OR 50 mM CHIR (C,F,I) and analysed by immunohistochemistry for the expression of Sox9
(A–C), GFAP (D–F), Pax2 (G–I) and Calbindin (J–L). (M) Graph showing the proportion of Sox9+ cells in specific regions of cultured slices. (N,O) qRT-PCR
analysis of expression of Sox9 (N) and Gfap (O) expression, relative to EIF4A2 control. (P) Graph showing the proportion of Pax2+ cells in specific
regions of cultured slices. (Q) Graph showing the proportion of Calbindin+ cells in the dorsal region of each slice. In all cases, direct comparisons were
made by comparing each treatment group with the relevant DMSO control with a Student’s T-test. For each test, n = 3, error bars = SEM, * = p,0.05,
** = p,0.01, *** = p,0.001. All sections counterstained with TOPRO3. Scale bar = 100 mm.
doi:10.1371/journal.pone.0042572.g003
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proportion of GFP+ cells that expressed PCNA in Apclox/lox
embryos (13.4%63.5%) compared to that in Apclox/+ controls
(31.1%64.2%) (Fig. 6I). Therefore, activation of Wnt/b-catenin
signalling in vivo during this window led to an apparent reduction
in proliferation.
Discussion
Wnt/b-catenin signalling can be activated in the
developing cerebellum ex vivo and in vivo
Following up on our previous finding that Wnt/b-catenin
signalling is active at the perinatal VZ [33] we set out to investigate
the normal function of this pathway in cells generated at the VZ
during this developmental window. The VZ gives rise to both
interneurons and glia at this time point and we first examined
whether Wnt/b-catenin activity was restricted to one or other
lineage. Analysis of BAT-gal Wnt/b-catenin reporter mice [34]
revealed that the clear majority of cells expressing the reporter also
expressed the glial/progenitor marker Sox9 [37,38,39] (Fig. 2F),
but not the early interneuron lineage marker Pax2 [36] (Fig. 2C).
This suggests that Wnt/b-catenin signalling activity is restricted to
progenitor cells and/or cells entering the glial lineage, and is lost in
cells that enter the interneuron lineage. Based on this observation,
we hypothesised that Wnt/b-catenin signalling activity could play
a role in VZ progenitor regulation or in development of the glial
lineage. We therefore tested the effects of activating Wnt/b-
catenin function in two experimental settings, pharmacological
intervention in ex vivo slice culture and in vivo genetic manipulation
via in utero electroporation.
We cultured slices of E18.5 BAT-gal+ cerebellum in the
presence of GSK3b inhibitors BIO and CHIR. In both cases we
observed a significant increase in the proportion of cells expressing
the BAT-gal reporter (Fig. 2D,E,G) and the endogenous Wnt/b-
catenin target Axin2 (Fig. 2F) after 24 hours, confirming successful
activation of the pathway. To complement this in vitro approach,
and to target the VZ specifically, we also activated Wnt/b-catenin
signalling at the VZ in vivo by electroporating a Cre-GFP expression
construct [50] into the fourth ventricle of E13.5 Apclox/lox embryos
[49]. Analysis of GFP expression after 24 hours showed that VZ
cells lining the fourth ventricle had taken up and expressed the
plasmid (Fig. 2B) and by E18.5 GFP+ cells were distributed
extensively through the cerebellum (Fig. 2C–D). b-catenin protein
was found in the nuclei of the majority of GFP+ cells at E18.5,
clearly indicating successful activation of Wnt/b-catenin signalling
activity (Fig. 2E–G).
Activation of Wnt/b-catenin signalling inhibits expression
of VZ-derived lineage markers Sox9 and Pax2
Numerous lines of evidence suggest that Wnt/b-catenin
signalling plays a role in regulating the proliferation, self-renewal
and differentiation of radial glia within the developing cortex
[50,51,52,53,54,55,56]. We therefore asked whether it may have a
similar function in regulating development at the cerebellar VZ.
The most striking effect of activating Wnt/b-catenin signalling ex
Figure 4. Wnt/b-catenin pathway activation ex vivo is mitogenic but has no affect on apoptosis. E18.5 cerebellum slices were cultured in
the presence of DMSO (A,D), 20 mM BIO (B,E) or 50 mM CHIR (C,F) and analysed by immunohistochemistry for the retention of a BrdU label
administered two hours prior to fixation (A–C) or apoptotic marker Caspase3 (D–F). (G) Graph showing proportion of BrdU+ cells in specific areas of
cultured slices. (H) Graph showing density of Caspase3 labelled cells per unit area in specific regions of cultured slices. In all cases statistical
comparisons were made by comparing each treatment group with the appropriate DMSO control using a Student’s T-test. For each test, n = 3, error
bars = SEM, * = p,0.05, ** = p,0.01, *** = p,0.001. All sections counterstained with TOPRO3. Scale bar = 100 mm.
doi:10.1371/journal.pone.0042572.g004
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vivo and in vivo was the consistent reduction in Sox9 expression in
cells at, and arising from, the VZ (Fig. 3A–C, M–N and Fig. 6A–
C). Analysis of a further glial/progenitor marker GFAP in the
cerebellum slices treated ex vivo revealed a similar effect (Fig. 3D–F,
O), consistent with the suggestion that reduced Sox9 expression
indicates a decrease in the number of these cells, rather than a
specific effect on the expression of one protein.
We also found a differential effect on generation of Pax2+
interneurons in both experimental systems. While the slices treated
ex vivo revealed a modest reduction in Pax2 expression in cells that
had migrated away from the VZ (Fig. 3G–I, P), activating Wnt/b-
catenin signalling in the VZ in vivo caused more widespread
reduction (Fig. 6D–F). This most likely reflects the different
methods of pathway activation employed and the fact that in the
latter, analysis was carried out a number of days after activation of
the pathway while in the ex vivo experiment analysis was carried
out after only 24 hours. However, if activation of the pathway does
indeed have an inhibitory effect on normal development from the
Sox9+ radial glia within the VZ, then it is not unreasonable to
conclude that activating the pathway at the earlier stage in the in
vivo experiments would cause a more profound effect on the
development of the Pax2+ interneuron lineage from these
progenitors. Furthermore, the reduction in Pax2+ cell number
observed ex vivo at the periphery of each slice argues for an
additional disruption during the later stages of interneuron
development. While both these points now warrant further
investigation, our preliminary data would suggest that Wnt/b-
catenin signalling could be required at multiple stages in the
development of glial and interneuron lineages from the VZ.
Figure 5. Genetic activation of Wnt/b-catenin signalling in VZ-
derived cells by in utero electroporation. (A) Schematic illustration
showing in utero electroporation technique. E13.5 Apclox/lox or Apclox/+
embryos were injected in utero with a Cre-GFP plasmid delivered to the
fourth ventricle and electroporated. (B) GFP expression in an
electroporated embryo at E14.5, revealing extensive expression along
the VZ. (C, D) By E18.5 GFP expression was widespread throughout the
developing cerebellum of both Apclox/+(C) and Apclox/lox (D) embryos.
(E–G) High magnification analysis of GFP+ cells revealed that majority of
them also displayed ectopic nuclear accumulation of b-catenin (white
arrowheads) compared to non-GFP cells (empty arrowheads). All
sections were counterstained with TOPRO3. CP = choroid plexus,
DHB=dorsal hindbrain, EGL= external granule layer, IV = fourth ventri-
cle, URL =upper rhombic lip, VZ = ventricular zone. Scale bar = 100 mm
(A–C), 10 mm (D–F).
doi:10.1371/journal.pone.0042572.g005
Figure 6. Effects of in vivo activation of Wnt/b-catenin
signalling on development of VZ-derived cells. Apclox/+ and
Apclox/lox embryos were electroporated with a Cre-GFP plasmid at E13.5
and analysed at E18.5. Electroporated cells and their progeny, marked
by expression of GFP, were examined for expression of Sox9 (A–C), Pax2
(D–F) and PCNA (G–I). Immunohistochemical analyses were quantitated
by counting the number of GFP+ cells expressing each marker (white
arrows) as a proportion of total GFP+ cell numbers per section and
comparing by Student’s T-test between the two genotypes for each
marker. For each test, n = 4, error bars = SEM, * = p,0.05, ** = p,0.01,
*** = p,0.001. Scale bar = 25 mm.
doi:10.1371/journal.pone.0042572.g006
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Activation of Wnt/b-catenin signalling does not
consistently alter proliferation and apoptosis
As Wnt/b-catenin signalling is known to be mitogenic and can
promote both cell survival [57,58,59] and apoptosis [60,61]
depending on context [62], we investigated whether effects on
these processes could underlie the observed reduction in Sox9 and
Pax2 expressing cells. In the ex vivo cultured cerebellum slices, we
observed an increase in BrdU label retention in all cell regions
except the EGL after treatment with both BIO and CHIR
(Fig. 4A–C, G), suggesting that activating Wnt/b-catenin activity
has a mitogenic effect in this context. In contrast, the embryos
analysed after targeting Apc function in vivo revealed a reduction in
expression of PCNA in the electroporated cell population (Fig. 6G–
I), suggesting a reduction in proliferation of these cells. However,
the observation that the total number of electroporated (GFP+)
cells did not differ between the two Apc genotypes argues that this
reduction in proliferation within the Apclox/lox embryos is not the
result of a dramatic or sustained effect on cell cycle.
While at first these observations appear inconsistent and the
different model systems employed make comparison difficult, our
data suggest that activation of the Wnt/b-catenin pathway elicits
a differential response depending on the developmental window
during which activation takes place and the length of time
allowed for an effect to become manifest. This conclusion is
supported by recent findings from Pei et al. [22], who
demonstrated using both in vitro and in vivo models that
constitutive activation of Wnt/b-catenin signalling in VZ
progenitors during embryogenesis is mitogenic initially, but this
effect is not sustained and by P0 a severe effect on self-renewal
and differentiation of these progenitors is observed. The
conclusion that Wnt/b-catenin signalling could function differ-
ently at discrete stages in development is further supported by
investigation during cortical development, where activation of the
pathway in neural stem cells (NSCs) causes increased self-renewal
and an expansion of the NSC population [51], while activation of
the pathway in the more restricted intermediate progenitor cell
population promotes differentiation and causes a depletion of the
progenitor pool [52,54].
While a precise developmental function for the Wnt/b-catenin
pathway throughout the key stages of cerebellum development
awaits further clarification, taken together our findings support
the conclusion that activation of the Wnt/b-catenin pathway at
the VZ during late embryonic development leads to a decrease
in the output of Sox9, GFAP and Pax2 expressing cells from the
VZ and early WM, most likely as a result of altered differ-
entiation.
Methods
Ethics statement
The licence authorising this work was approved by the
University of Edinburgh’s Ethical Review Committee on 22nd
September 2008 (application number PL35-08) and by the Home
Office on 6th November 2008. Animal husbandry was in
accordance with the UK Animals (Scientific Procedures) Act
1986 regulations. To minimise animal suffering, pregnant dams
were culled by cervical dislocation under terminal anaesthesia
according to the Code of Practice for Humane Killing of Animals
under Schedule 1 to the Animals (Scientific Procedures) Act 1986
issued by the Home Office.
Mice
The day on which the vaginal plug was detected was designated
E0.5 and the day of birth as P0. BAT-gal mice were maintained as
hemizygotes on a C57BL/6J background and were genotyped as
described previously [34]. Mice carrying the Apclox allele were
maintained on a CBA/C57Bl/6J genetic background. Genotyping
was carried out as described previously [49].
Organotypic culture methods
Ex vivo organotypic slice culture procedures generally followed
those of Anderson et al. [63]. E18.5 embryos were dissected in 16
Kreb’s buffer on ice. Brains were removed and placed into 16
Kreb’s buffer with 10 mM HEPES buffer (Invitrogen), Gentami-
cin (Sigma) and Penicillin-Streptomycin (Invitrogen). The cere-
bellum and surrounding tissue was microdissected and embedded
in molten 4% LMP agarose (Seakem)/PBS at 43uC with stirring
and solidified on ice. Tissue was sectioned sagitally on a vibratome
at a thickness of 300 mm. Slices were collected into 16 Kreb’s
buffer with HEPES and antibiotics on ice. Collected Vermis slices
were transferred onto polycarbonate membranes (10 mm, 8 mm
pore, Whatman) floating on 2 ml of 10% FCS (Gibco) and 0.5%
glucose (Sigma) supplemented MEM (Gibco) with Penicillin-
Streptomycin in a 7 cm Petri dish. Slices were allowed to recover
at 37uC with 5% CO2 for one hour before media was replaced
with serum-free neurobasal medium (Gibco) supplemented with
2% B-27 (Sigma), glucose, L-glutamine and Penicillin-Streptomy-
cin. Small molecule GSK3b inhibitors were dissolved in DMSO
and added to pre-warmed Neurobasal medium+supplements at a
final concentration of 20 mM for BIO (Sigma) and 50 mM for
CHIR (Cambridge Biosciences). This was added to the slice
cultures after they were allowed to equilibrate to the Neurobasal
medium+supplements and then cultured for 24 hours. 2 hours
prior to the end point BrdU was added to the medium at a final
concentration of 10 mg/ml.
In utero electroporation
E13.5 timed pregnant females were anaesthetised by inhalation
with isoflurane and maintained in anaesthesia with O2 delivered
through a facemask. Uterine horns were surgically exposed and
approximately 3 ml of purified pCAG-Cre-IRES2-EGFP plasmid
DNA [50] (.1.5 mg/ml) in H2O with 2 mg/ml Fast Green
(Sigma) was injected into the fourth ventricle to each embryo
using pulled glass capillaries inserted through the roof plate into
the ventricle. A PV820 Picrospritzer (WPI) was used to deliver
short bursts of plasmid solution until the Fast Green dye was
visible filling the ventricle. Forceps-type electrodes (7 mm,
Harvard Apparatus) were positioned around the midbrain-
hindbrain boundary of embryos outside the uterine wall (anode
oriented to the right) and a CUY21 electroporator (Nepa-gene)
was used to deliver five pulses with the following parameters:
intensity = 45 V, pulse length = 50 ms, pulse interval = 950 ms.
At the end of the procedure uterine horns were repositioned in
the abdomen and the smooth muscle lining was closed with grade
5 sutures and the skin was closed with 5 mm wound staples.
Brains were dissected at defined stages during embryonic
development and those with successful electroporations were
identified by epifluorescence microscopy for GFP expression
within the cerebellum.
Histology
For in vivo analysis, heads were collected from E14.5 embryos
and brains were dissected from E18.5 embryos. For all histological
analysis, including cultured cerebellum slices, tissue was immersion
fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4uC.
Tissue was then cryoprotected in 30% sucrose/PBS overnight
before embedding in 30% sucrose/OCT (1:1) and snap freezing.
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Sections were cut on a cryostat at a thickness of 12 mm for ex vivo
slices and 14 mm for in vivo tissue.
Fluorescent immunohistochemistry
Immunohistochemistry and immunofluorescence were per-
formed according to standard protocols. Antigen retrieval was
achieved by microwaving sections on medium power in 10 mM
citrate buffer (pH6.0) for five minutes followed by 15 minutes at
low power. Primary antibodies were rabbit anti-b-galactosidase
(Molecular Probes, 1:500), mouse anti-b-galactosidase (DSHB
1:100), mouse anti-PCNA (Abcam, 1:500), mouse anti-Pax2
(Covance, 1:200), goat anti-GFP (Abcam, 1:400), rabbit anti-
GFP (Abcam, 1:1000), rabbit anti-Sox9 (Millipore, 1:1,000),
mouse anti-b-catenin (BD Biosciences, 1:500), mouse anti-BrdU
(BD Biosciences, 1:50), mouse anti-Caspase3 (NEB, 1:50) and
mouse anti-Calbindin (Swant, 1:1000). All primary antibodies
were detected using goat anti-rabbit IgG, goat anti-mouse IgG or
donkey anti-goat IgG secondary antibodies conjugated to Alexa
fluor 568 or 488 dyes (Invitrogen, 1:200) and sections were blocked
using serum from the secondary host species. Appropriate controls
were used in all cases by incubating sections with all but the
primary antibodies. No staining was observed under these
conditions. Nuclear counterstaining was performed with TO-
PRO-3 (Invitrogen, 1:1000).
Microscopy
A Leica brightfield microscope connected to a Leica DFC360Fx
camera was used to capture images of fluorescently labelled
sections. Confocal microscopy for high resolution image analysis
was carried out in the IMPACT Imaging Facility at the University
of Edinburgh using an inverted Zeiss LSM510 confocal micro-
scope.
Quantitation of BAT-gal+ cells
Counting frames were placed in four defined regions of each
section analysed (Fig. 2D): three along the anterior-posterior
extent of the EGL, and one ventrally covering the VZ and the area
immediately dorsal to it. The dorsal frames were further
partitioned to exclude the EGL from the region inferior to it as
the EGL contains a distinct cell population not of VZ origin.
Quantitative gene expression analysis
RNA extraction for reverse transcriptase PCR (RT-PCR) was
performed on individual snap frozen cerebellum slices using an
RNeasy Microkit (Qiagen) following the manufacturer’s instruc-
tions. On-column DNA digestion was performed in all cases
during extraction to eliminate genomic DNA contamination.
cDNA was synthesised from 50 ng RNA (measured by
Nanodrop, Thermo Scientific) using a Sensiscript reverse
transcription kit (Qiagen). The reactions were prepared with
50 ng sample RNA added to 16 RT-Buffer, 10 mM random
hexamer primers (Promega), 0.5 mM dNTPs (Invitrogen), 10 u
RNAse inhibitor (Promega), 1 ml Sensiscript reverse transcrip-
tase and made up to 20 ml with nuclease free water. Identical
reactions were set up in tandem excluding reverse transcriptase
(2RT) to serve as negative controls for possible genomic DNA
carryover. Reactions were carried out at 37uC for 60 minutes
and stored at 220uC. Quantitative RT-PCR (qRT-PCR) was
performed using a Precision qPCR SYBRgreen detection kit
(PrimerDesign) and commercially synthesised primer pairs
(PrimerDesign) with an Opticon DNA Engine (MJ Research)
following the manufacturer’s instructions. All primers used had
annealing temperatures of ,58uC and an amplicon size of 90–
120 bp. Reactions were prepared in 20 ml with Precision qPCR
mastermix (PrimerDesign), 300 nM custom primer pairs, 0.5 ml
cDNA and made up to 20 ml with nuclease free H2O. Reactions
were set up in a 96 well white PCR plate (Bio-Rad) using a
QIAgility automated pipetter (Qiagen). H2O and –RT negative
controls were included for each gene tested. Each reaction was
begun with a 10 minute 95uC denaturation step followed by 40
cycles of: 15 seconds at 95uC, 60 seconds at 60uC. Fluorescence
was monitored at each cycle and then a melt curve analysis was
performed.
For each gene analysed a set of six two-fold serial dilutions of
control cDNA (a pooled collection of all sample cDNAs
analysed) was tested in order to generate a standard curve of
arbitrarily assigned transcript units. Quantitation was carried
out by comparing the relative amounts of gene-specific template
cDNA to a housekeeping reference gene. The appropriate
reference gene for analysis was identified using a GeNorm
reference gene selection kit (PrimerDesign). This involved a test
of six common reference genes by qPCR with a sample of the
test cDNA followed by statistical analysis using qBasePLUS
(BioGazelle). This analysis determined EIF4A2 as the optimal
reference gene. Relative amounts of transcript for each gene
analysed were normalised to EIF4A2 in each case and expressed
as a ratio. For every gene analysed, samples were run in
triplicate using cDNA collected from three individual slices from
each sample group.
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